EPGL Med ?@EPGLMed Manuel, OTCQX SEC full repor
Post# of 98056
Manuel, OTCQX SEC full reporting will be .10 cents requisite share price to achieve that status. This is in our plans.
David, EPGL has a history with the US Military and DARPA via team members. We can only say, stay tuned for future developments
Yes, Our SEC counsel will be submitting a letter to OTC shortly and EPGL will be OTC Current Information status as previously stated.
John, We intend for the market to become more and more aware of EPGL via release of news and information, not cheesy stock promotion.
Binayak, the two major shareholders have agreed to provide the necessary equity to the company any agreed upon...strategic relationships or capitalization. So, no, there will not be another reverse split or restructuring. Management and the major..shareholders are dedicated to bringing significant value for the shareholders. You do not bring significant value by creating uncertainty.
Yes, We will be OTC Current very shortly and yes we are continuing with plans to move to OTCQX. Nothing has changed there.
We have six additional devices that will be in the EPGL pipeline in addition to the MPDD and MPTT.